Activase Patient Assistance Program
Don’t let the high cost of brand tissue plasminogen activator disrupt access to critical thrombolytic therapy. We help eligible patients access Activase (alteplase intravenous infusion) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Activase (alteplase, recombinant tPA) is FDA-approved for acute ischemic stroke (within 3–4.5 hours of symptom onset), acute massive pulmonary embolism, acute STEMI, and to restore function to central venous access devices (Cathflo Activase). Time-critical emergency thrombolytic — administered in hospital emergency or ICU settings, not outpatient.
- Without assistance, Activase costs commonly run approximately $6,000–$9,000 per dose for acute stroke/PE indications.
- Through AffordMyPrescriptions, qualifying patients can access Activase for a flat $69.95 per month coverage.
- Newer tPA option: tenecteplase (TNKase — single IV bolus, simpler than Activase's 60-minute infusion, non-inferior for acute stroke per AcT/ATTEST). Cathflo Activase for CVAD restoration is a different product. Mechanical thrombectomy for large vessel occlusion stroke. Standard STEMI now primary PCI when available.
What is Activase Prescription Assistance Program?
The Activase Patient Assistance Program is a manufacturer-sponsored initiative that helps eligible patients access Activase (used for acute ischemic stroke, acute massive pulmonary embolism, STEMI, and central venous access device restoration) at little or no cost when they meet specific income, insurance, and clinical criteria. The program is free to apply for, but enrollment involves detailed applications, emergency medicine or specialty coordination, supporting documentation, and ongoing renewal.
At AffordMyPrescriptions, our Patient Advocates handle the entire Activase PAP enrollment for a flat $69.95 per month. We complete the application, coordinate with your treating clinicians for required documentation, follow up with the manufacturer’s program until approval, manage the hospital coordination, and handle annual re-certification.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Activase enrollment — from the initial application through hospital administration coordination and re-enrollment — so you never face a gap in your acute stroke, PE, or MI thrombolytic treatment.
Pharmacy Price Comparison
- Without assistance, Activase costs thousands of dollars per dose at hospitals. Discount cards offer no relief for emergency inpatient administration, but a Patient Assistance Program can help offset hospital billing exposure if you qualify. The table below compares typical pricing to what you'd pay with our Activase advocacy service:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Mechanical thrombectomy (alt) | hospital | Procedural alt for LVO |
| Hospital ED/ICU acute stroke | ~$8,500/dose | Save substantially |
| Community hospital | ~$7,500/dose | Save substantially |
| 340B-eligible institution | ~$6,000/dose | Save substantially |
| TNKase (tenecteplase alt) | ~$5,500/dose | Alt bolus tPA, simpler |
| Cathflo Activase (CVAD) | ~$150/dose | Different formulation |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Activase — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Activase Prescription Program?
The Activase Patient Assistance Program is free to apply and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95 per month covers full advocacy: applications, doctor coordination, documentation, hospital billing coordination, and re-enrollment. Tenecteplase (TNKase) is now increasingly preferred at many stroke centers due to simpler single-bolus administration.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Activase assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Activase is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Activase:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $6,000–$9,000/dose per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Activase assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Activase Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Activase:
Activase is recombinant human tissue plasminogen activator (tPA) — activates plasminogen to plasmin, which lyses fibrin clots. Time-critical thrombolytic for acute ischemic stroke, massive PE, and STEMI. Administered exclusively in emergency/ICU/inpatient settings. Not appropriate for outpatient use.
How It Works:
Acute ischemic stroke, massive pulmonary embolism, and STEMI involve arterial or venous occlusion by thrombus — causing tissue ischemia and cell death. Rapid clot lysis restores perfusion, salvages threatened tissue, and improves outcomes. Alteplase binds fibrin in thrombi and activates plasminogen locally to plasmin, which cleaves fibrin, dissolving clot. Fibrin-selective. Time-dependent efficacy — ‘time is brain’ for stroke, ‘time is muscle’ for MI. Standard weight-based dosing regimens for each indication.
Form and Use:
Activase IV infusion. Acute ischemic stroke: 0.9 mg/kg (max 90 mg) — 10% as IV bolus over 1 min, remainder over 60 min. Acute PE: 100 mg IV over 2 hours. STEMI: weight-based accelerated regimen. Cathflo Activase for CVAD: 2 mg in 2 mL locked in catheter. Requires ICU-level monitoring; strict inclusion/exclusion criteria per stroke protocols.
Generic Availability:
No biosimilar/generic. TNKase (tenecteplase) is genetically modified tPA — single 5-second IV bolus (vs Activase 60-min infusion), non-inferior in acute stroke per AcT and ATTEST trials, and increasingly preferred at stroke centers. Cathflo Activase is same active drug at lower dose for CVAD restoration. For LVO stroke: mechanical thrombectomy is standard when available. For STEMI: primary PCI preferred. For VTE: anticoagulation is standard; thrombolysis reserved for massive/unstable PE.
Warnings:
Boxed warning class: bleeding is the major adverse effect — most serious intracranial hemorrhage (2–7% in stroke thrombolysis), systemic bleeding at any site. Contraindications include recent surgery/trauma/GI bleeding, uncontrolled hypertension, active bleeding, recent stroke or intracranial hemorrhage, brain tumor, arteriovenous malformation, aneurysm, coagulopathy, anticoagulant use, thrombocytopenia. Strict adherence to inclusion/exclusion criteria essential. Allergic reactions rare, cholesterol embolization, arrhythmias post-STEMI thrombolysis.
FAQ (Frequently Asked Questions)
How much does Activase cost without insurance?
$6,000–$9,000 per dose for acute stroke, PE, or STEMI. Cathflo Activase for CVAD restoration costs around $150 per dose. Emergency thrombolytic administration is typically covered by hospital emergency billing; Patient Assistance Programs help with out-of-pocket exposure.
What is the difference between Activase and TNKase (tenecteplase)?
Both are recombinant tPA thrombolytics. Activase is a 60-minute infusion. TNKase is a genetically modified variant given as a single 5-second IV bolus — much simpler. TNKase is non-inferior in acute stroke (AcT, ATTEST trials) and increasingly preferred at stroke centers.
Is Activase used outside the hospital?
No — Activase for stroke, PE, or STEMI is administered exclusively in emergency departments, ICU, or inpatient settings with strict monitoring. Cathflo Activase for central venous catheter restoration is used in clinic settings for a different indication.
What is 'time is brain' for acute stroke thrombolysis?
Faster stroke thrombolysis means better outcomes. Activase must be given within 3 hours (or 4.5 hours for extended-window criteria) of symptom onset for benefit. Every minute of delay costs roughly 1.9 million neurons. Anyone with suspected stroke should call 911 immediately.
What are the FDA boxed warnings for Activase?
Bleeding — including potentially fatal intracranial hemorrhage. Strict inclusion/exclusion criteria per stroke protocols identify appropriate candidates and exclude high-bleeding-risk patients. Recent surgery, trauma, uncontrolled hypertension, active bleeding, and anticoagulation preclude use.
Take Control of Your Medication Costs
Emergency thrombolytic therapy for acute stroke, PE, or STEMI should not be derailed by cost. Our Activase advocacy team can help with post-treatment billing coordination and eligibility for programs — for a flat $69.95 per month. If we cannot help you access Activase through a Patient Assistance Program, you are not charged.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.